RajasthanAn Ideal Bio Technology Destination |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1.0
Introduction Bio Technology is a frontier area of Science and
Technology with a high promise for the welfare of humanity. A new generation
of biotechnology developed as a result of intensive work in India has opened
up new opportunities for economic development in the country. The country is also rapidly emerging as a major
market for biotech products. The current consumption of biotechnology products
in India is of the order of Rs. 87 billion which is expected to increase to
Rs. 234 billion by 2010. The healthcare sector would contribute 38% of the
market, agriculture 32% and industrial products 30%. The small scale sector
is expected to play a major role in the growth of the biotech industry. There is widespread acceptance of the fact world
over that Biotechnology alongwith Information Technology is going to be a
major thrust area in the times to come. Of late, the announcement of Human
Genome sequence and the progress made in the fields of Biogenetic and Bio
Informatics in the last two decades have led to the growth of Biotechnology
as a prominent industrial activity. Rajasthan is very rich in Bio resources. The State
provide tremendous bio diversity, rarely to be found in any other State.
Agricultural and Forest produce have been the main source of the state
economy for quite some time now. It is, therefore, necessary to lay more
stress on this sector. Biotech application such as transgenic crops can
significantly benefit this sector. The State is a leading producer of
mustard, rapeseed, soyabean, barley, maize, wheat, cotton, groundnut, milk,
etc. Fruits and vegetables, such as Potato, Tomato and Onion are also
available in abundance. There is vast scope of quality improvement of cotton.
In addition, there are various varieties of exotic Indian spices in the
State. Thus, integrated horticulture development would improve the
availability of raw material for food processing industries in the State. Rajasthan is very rich in cattle breed also.
Improved species of camel, sheep, rathi cows, nagouri bullocks etc hold great
promise of research and development in biogenetics. State has highest
livestock population and there is good potential in animal husbandry and
genetic engineering. Thus Rajasthan has great potential to create
immense industrial activity in Biotechnology and modern Biotech products
involving recombinant DNA based products and Bio Informatics. In line
with the developed world, the Government would make all efforts to focus on
modern processes in the area of agriculture industry, floriculture, human and
animal health care (medical and veterinary science) and environment to
provide good commercial opportunities in the field of Biotechnology. 2.0
Biotechnology Industry - India Biotech in India began during the mid- 1980s, but
was concentrated with large domestic or multinational drug firms. Several
small biotech companies have recently been established. In 1999 the biotech
market in India was estimated at US$ 800 million and is expected to be around
US$ 5 billion in 2001. Indian biotech industry employs about 10,000 people,
which is expected to grow to 50,000 (research 50%, technical / services 35%,
management 15%) by the end of 2008. In the global biotech market, Indian share is
presently about 2%. Consumption of biotech products in India was to the tune
of INR 71,540 mn during 1997, which is expected to grow up to INR 145,870 mn
by the end of year 2008. Around 72% of the consumption of biotech products in
1997 was met through local production. While there are about 800 companies operating in all
sectors of biotechnology in India, there are only about 30 companies that are
working in modern biotech sectors. Few players have teamed up with foreign
companies for sourcing technologies, and are experimenting with new products
produced by foreign technologies with a view to introduce them in the Indian
market, within the frame work of Indian laws. India is taking steps to rationalise its policies to
be in conformity with the provisions of the WTO. There are several advantages
in the setting up of modern biotech industries in the country as it has core
competence in some areas like skilled manpower and several R&D
institutes. Research institutes and centres like CSIR, ICAR, ICMR, CDFD,
CCMB, IISc and IICB presents large technical resource base. Indian biotech
sector is showing an impressive growth mainly due to increasing collaboration
of multinational companies or big Indian pharma companies with these
indigenous research institutes. Although most of the biotech products are
currently produced by imported technologies, but few diagnostics, plant
tissue culture products, and a recombinant hepatitis B vaccine have been
developed and marketed locally. In India the largest market segment has been for the
health care biotech products, which accounted for 53% of the total biotech
industry in 1995. In the year 2000 it has risen to 60% but still the largest
market share. Biotech products related to human health in the country are
mostly for diagnostic and research purposes, such as antibodies for disease
immunodiagnosis, tissue typing, and other clinical tests. Kits for blood
grouping and detection for pregnancy, amebiasis, typhold, hepatitis B, and
malaria have been developed locally. The Indian pharmaceutical market is also growing
exponentially, its value in 1997 was US $ 3bn, and is expected to rise to US$
9 bn by the year 2008. Accordingly to Fici-McKinsey study Indian
pharmaceutical industry is poised to grow to an innovation-led US$ 25 bn
industry by 2010 with a market capitalisation of almost US$ 150 bn from the
current US$ 5 bn generic-based drug industry. Health care biotech market in India is primarily
divided into:- Vaccine market:- The vaccine market at present is estimated at US$
100 mn and is growing at 20 percent annually. Diagnostic market India's diagnostic
market is expected to be around US$ 200 mn in 2001, with increasing demand
for veterinary vaccines, diagnostics, therapeutics and protein feed. Veterinary biotech:- With increasing domestic demand for veterinary
vaccines, diagnostics therapeutics, and protein feed, the market for
veterinary biotech products is expected to reach US$ 500 mn by the year 2008.
Many multinationals have set up subsidiaries in India; for example, ELi
Lilly- Ranbaxy will be marketing Monsanto's DNA recombinant bovine growth
hormone to increase milk production. India has a tremendous potential in Agbio being the
second largest food producer in the world after China. As there is an
increasing pressure to produce more food using lesser resources, GM food
products is expected to hit the Indian markets in the next five years. Being
agriculture based country; India has huge opportunity in agricultural biotechnology
R&D and in its commercialisation. About 400 organisations are doing
commercial research on agriculture: 200 research labs, 150 companies and 50
service firms, Medical foods and nutraceuticals sectors are also under
development. Today, nutraceuticals market stands out to INR 25,000-30,000 mn
(US$ 532-638 mn). India aspires to become the world's largest exporter
of agricultural products by the year 2010. The market for seeds in India was
about US$ 750 mn in the year 1999, of which genetically engineered seeds
account for US$ 250 mn. The total seed market is expected to increase to US$
5 bn by the year 2008, where genetically engineered seed market stands out to
be US$ 500 mn. There are about 50 private seed companies in India with total
annual sales of US$ 0.5 mn. Monsanto, one of the largest agricultural
companies in India, it planning to Introduce genetically engineered corn,
soybean, and cotton to India. Consumption
of Biotech Products in India and Future Estimates (INR mn)
(Source: "Future of Biotechnology in
India", Dr. P.K. Ghosh, Adviser, DBT. Figures in brackets indicate
contribution in % of the total) Among the industrial products, new investment opportunities
are foreseen in industrial enzymes (over INR 500 mn), and in amino acids
production where investment of over INR 700 mn is expected to come up to meet
both domestic and foreign market needs. India with its wide scientific pool and widening, resource
base is slowly but steadily preparing itself for the biotechnology challenge.
The emphasis today is on technology absorption, more influx of funds by
venture capitalists and strengthening of links between the industry, academic
and government institutions. SWOT ANALYSIS
3.0
Opportunities in Rajasthan The
opportunities in Biotechnology are numerous and multi-faceted. They are
growing in diversity and market value very rapidly. 3.1 Bio Informatics and Genomics. Information
Technology is going to play a major role in the functional development of new
genomic medicines, the expected market for which shall be 200 billion US
dollars around 2010. Infotech professionals from the State shall get work
from large industries and international genomic houses, which are likely to
out-source their requirements. Bioinformatics, broadly means, the interface
between Biology and information Technology. This uses computing and data
based techniques to describe and analyses the complex information on protein
and gene sequences derived from such work as the Human Genome Project. The Human Genome Project (HGP) was the first mega project in biology, involving international participation and public and private partnership. 3.2 Agriculture Agriculture
food products like mustard, soyabeen, rapeseed, barley, maize, wheat, cotton,
groundnut, fruits and vegetables, spices etc. which have a strong presence in
Rajasthan, could be targeted for Biotechnology research.
Rajasthan is leading producer of the following crops in the country
Reference: Economic Intelligence Service, CMIE,
Nov.'2001 A
few more areas of focus in agriculture based sector are:- Bio Pesticides and Bio Fertilizers, Development of heritable traits responsible for
various abiotic stresses like drought, temperature and salinity in crop
improvement. Genetic improvement of Animal breeds, Transgenic Seeds for Dry farming, Development of Bio fuel. Development of genomic medicines.
3.3 Pharmaceuticals
and Contract Research Organisations The
trend to outsource low cost R&D capabilities in biotechnology is increasing.
This represents a tremendous opportunity for Indian companies to do contract
research for overseas corporations. The current global spends on out sourced
R&D is approximately $7 billion and is expected to grow at 30% per annum
for the next 5 years. Typically, opportunities exist in basic gene sequencing
work, DNA library preparation, genetic research related to medical
diagnostics, new crop varieties and early stage drug development. Large
multinational corporations follow a strategy of subcontracting parts of their
R&D programmes to smaller and lower cost companies and derive benefits in
costs as well as time. The key stakeholders in this segment would be pharma companies, entrepreneurs, research institutions (public & private), R&D facilities, funding agencies and educational institutes. Contract
Research Organisations (CROs) have great potential to function as export
oriented units and are comparable in their activity to the software
development activities in the IT sector. Software services were outsourced by
the large overseas IT companies in a very similar manner, starting initially
with the sub-contracting software development of small modules of complex
software and a decade later, the Indian IT sector is now capable of handling
the entire software, the primary reason for the prolific growth in the IT
sector. Contract research in Biotechnology offers the same template of growth
and the Government of Rajasthan is firmly committed to supporting these
organizations 4.0
Existing Resources 4.1 Premier Institutions in Rajasthan The
premier institutions in Rajasthan which are offering education and research
facilities in Biotechnology are Agriculture University, Udaipur; Rajasthan
Agriculture University, Bikaner; University of Rajasthan, Jaipur; Agriculture
Research centre, Durgapura, Jaipur; Birla Institute of Scientific Research,
Jaipur; Central Arid Zone Research Institute (CAZRI), Jodhpur ; etc. These
institutes are involved in R&D activities covering Medicinal Plants,
Tissue Culture, Plant Genetics etc. BITS,
Pilani is offering courses in Bio Tech and Bio Science such as M.Sc., ME,
M.Pharma, B.Pharma etc. BITS Pilani is also engaged in research in various
areas of Bio technology and Bio sciences and working on various projects for
leading companies. This premier institutes can provide consultancy,
contractual research, training etc. in the Bio-technology sector. 4.2
Facilities available at R&D Centers in Rajasthan. The R&D Centers located at Agriculture Research Station, Durgapura, Jaipur; Rajasthan Agriculture University, Bikaner and Birla Institute of Scientific Research, Jaipur; Birla Institute of Technology and Science, Pilani are having sophisticated labs equipped with following facilities: Trinocolar Microscope with Micro-Zoom Photographic
attachment Elisa Reader Refrigerated Centrifuge Micro-Refrigerated Centrifuge Ultra-Centrifuge Deep Freezer (-80°) Disc/slab Gel Electrophoresis Densitometer Gel Documentation system with Image Analysis
Software Audio-Visual Equipments Genetic Analyser Tissue Culture Laboratory Reverse Osmosis Water Purifier System Rain-Out-Shelters Transilluminator Growth Chambers Green Houses 5.0 RIICO
extends a special land package to Modern Bio Tech Industries and Institutes
in the designated Bio Tech Parks Now the land allotment for setting up of various Bio-Tech and Bio-Informatics industries including projects covered under Modern Bio Technology, will be made at the rate of development charges prevailing in the area. The following entitled land rebate by way of reimbursement shall be allowed after stipulated minimum fixed investment is actually made on the allotted plot within the period stipulated for investment in the package. 1. Major Bio Technology and Bio Informatics Companies (annual turn over of more than Rs. 100 crores in this field as per the latest audited balance sheet) - For the industry which is set up on the allotted plot with a minimum fixed investment of Rs. 10 crores within a period of 4 years from the date of allotment in a specially designated Bio Technology parks/ zones, entitled land rebate shall be @ 60% of the allotment rate for the plot upto maximum of 10 acres area. 2. General Bio Technology and Bio Informatics Units- For the industry which is set up by any entrepreneur on the allotted plot in a specially designated Bio Technology parks/ zones with a minimum fixed investment of Rs. 15 lacs per 1000 sqm. within a period of 5 years, entitled land rebate shall be @ 40% of the allotment rate for the plot upto maximum of 5 acres area. Additional discount of 10% on allotment rate may also be allowed if the plot allottee commences commercial production within 3 years from the date of allotment. 3. General Bio Technology and Bio Informatics Training Institutes- No rebate in the allotment rate shall be allowed. However, RIICO may consider land allotment in any industrial area on the rate prevailing in the area. 4. Bio-Technology Industries outside the Bio-Technology Parks in Identified Industrial Areas - For the Bio Technology industries which is proposed to be set up outside the Bio Technology Parks in the Identified Industrial Areas, entitled land rebate shall be @ 10% of the allotment rate for the plot upto maximum of 4000 sqm. area. Notes- a) In case of failure to observe the terms and conditions regarding investment and time schedule mentioned in the package, the concessional amount shall be recovered from allottee with interest from the date on which concession amount has been reimbursed. b) In each case the decision of RIICO shall be final as to what qualifies as Bio-Tech Industry / Institute for the purpose of above said incentive. c) For reimbursement of the concessional amount, the plot allottee would be required to inform RIICO office by a registered AD letter sent prior to the scheduled date regarding the building construction. After verification by the Unit Head, the cheque or rejection letter, as the case may be, will be sent by RIICO within 30 days by registered AD letter. d) A committee of F.A., Advisor (Infra), Add.GM (T-Girish Gupta) and DGM (F-IP&I) shall identify industrial areas based on pace of allotment and put up to MD for approval, so that 10% rebate on prevailing rate of development charges subject to maximum of 4000 sqm. may be allowed. e) Definition of
Modern Bio Technology: · R&D and /or Manufacturing activities involving recombinant DNA Technology for bio Pharma, Agriculture, Health and Environment. · Areas of Genomics, Proteomics, Bio-informatics and Gene-Cloning. · Plant Tissue Culture research and development (Land upto maximum of 4000 sqm. may be allowed). · Active ingredient identification and preparations of Medicinal and Aromatic Plants and Herb- Bio processing. · Quality Assurance/ Quality Control Labs for recombinant DNA products/ GM Products. · Production of Industrial Enzymes. f) The cases for land allotment to Bio-Technology projects in Bio-Technology Parks and Identified Industrial Areas shall be put up to the Committee of GM(IT-BT), Advisor (Infra), F.A. and Add.GM(GG)- Member Secretary for view on project classification as Modern Bio-Tech or conventional Bio-Tech and to determine the permissible land rebate. MD is also authorised to review and make necessary changes in the guidelines for providing RIICO land for Modern Bio-Technology units from time to time.
6.0
Infrastructure for the Development of Biotechnology 6.1
Bio Tech Parks by RIICO Bio Tech Parks at two locations namely
Sitapura-Jaipur and Chopanki, Bhiwadi (Alwar) has been set up by RIICO. The
necessary common facilities such as incubators, R&D Centre etc.
will be encouraged in private sector. (i) Bio Tech Park at Sitapura,
Jaipur:- RIICO has developed Bio Tech Park in an area of
about 23.5 acres at Sitapura, Jaipur. The Park is located on Jaipur, Kota
national highway, just 4 kms. away from the Airport and about 15 Kms. from
the City Centre. 15 nos. of plots have been developed in the Park.
The size of the developed plots is ranging from 700 sq. mtrs. to 20,000 sq.
mtrs. Good quality Infrastructure such as Earth Station (for high speed data
com facility), Power, Telecom, Roads, Educational Institutions, Water supply
etc. are available in the park. Presently plots are not being
allotted/offered. (ii) Bio Tech Park at Chopanki-Bhiwadi (Alwar) RIICO has developed Bio Tech Park in an area of
about 14.5 acres at Chopanki (Bhiwadi). The Park is located about 5 kms. from
the Bhiwadi. 13 nos. of plots have been developed in the Park. The size of
the plots is ranging from 3000 sq.mtrs. to 4000 sq.mtrs. Good quality
infrastructure such as power, telecom, roads, water supply etc. is available
in the park. Presently plots are not being
allotted/offered. 6.2 The State Govt.
will also encourage development of Bio Technology Parks in private sector.
State Govt. would consider extending concessions to such Bio-Technology Parks
on case to case basis, to be decided at the level of SLEC/BIDIP. 7.0
Manpower:- BITS,
Pilani; Rajasthan Agriculture University, Bikaner; Agriculture University,
Udaipur and other Institutions offers courses (under graduates and Post
graduates) in Bio Tech, Bio Sciences etc. Most
of Universities and Colleges in the State are now offering B.Sc.(Bio-Tech)
and M.Sc.(Bio_Tech) courses. 8.0
Venture Capital Fund RIICO in association with SIDBI is operational a Venture Capital Fund known as Rajasthan Venture Capital Fund (RVCF) for providing Venture Capital to IT, Biotech and other knowledge based industries. For details, please contact: A.K. Gupta, General Manager/ Dinesh Pahadia, Dy. General Manager RIICO Limited, Udyog Bhawan, Tilak Marg, Jaipur
-302005 Tel. No.: 0141-
2227751/5113201, Fax No.: 0141-5104804, Email : akgupta@riico.co.in OR dpahadia@riico.co.in OR riico@riico.co.in |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||